NCT07450573

Brief Summary

Stage III, Grade B periodontitis is a severe form of gum disease that damages the tissues and bone supporting the teeth. It can cause loose teeth, difficulty chewing, and reduced quality of life. Although periodontal (gum) treatment is known to improve gum health, less is known about how it affects chewing ability and how patients feel about their oral health after treatment. This study looked at how comprehensive periodontal treatment affects gum health, chewing function, and oral health-related quality of life. Twenty patients with Stage III, Grade B periodontitis and twenty individuals with healthy gums participated. Patients with periodontitis received non-surgical treatment (deep cleaning and root surface debridement) followed, when needed, by surgical periodontal therapy. Researchers measured gum health (including probing depth and bleeding), tooth mobility, chewing performance, and patient-reported quality of life. Chewing performance was tested using a standardized chewing test with silicone material. Quality of life was assessed using a validated questionnaire (OHIP-14), which measures how oral health affects daily life, comfort, and well-being. Assessments were performed before treatment, after non-surgical therapy, and after surgical treatment. At the start of the study, patients with periodontitis had worse gum health, poorer chewing ability, and lower oral health-related quality of life compared to healthy individuals. After treatment, gum inflammation and tooth mobility significantly improved. Chewing ability also improved after therapy, especially after surgical treatment. Patients reported better quality of life, with fewer symptoms and less discomfort. The study also found that better chewing performance was strongly associated with better quality of life. This suggests that improving function is closely linked to how patients feel about their oral health. Overall, comprehensive periodontal therapy not only improves clinical gum health but also enhances chewing efficiency and patient well-being. These findings highlight the functional and quality-of-life benefits of periodontal rehabilitation in patients with advanced gum disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2021

Completed
4.6 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 4, 2026

Completed
Last Updated

March 4, 2026

Status Verified

February 1, 2026

Enrollment Period

1.6 years

First QC Date

February 21, 2026

Last Update Submit

February 26, 2026

Conditions

Keywords

periodontitisperiodontal therapymasticationquality of life

Outcome Measures

Primary Outcomes (6)

  • Plaque index

    Plaque accumulation was assessed using a standardized plaque index at four sites per tooth. The presence of visible dental plaque along the gingival margin was recorded following gentle probing and air-drying when necessary. Scores were assigned according to established criteria (0 = no plaque; 1 = plaque detectable with probe; 2 = visible plaque; 3 = abundant plaque accumulation). Mean plaque index scores were calculated per participant to reflect overall oral hygiene status. Higher scores indicate greater plaque accumulation and poorer oral hygiene.

    At Day 0, Day 30, Day 90

  • Probing depth

    Probing depth was measured in millimeters using a calibrated periodontal probe at six sites per tooth (mesiobuccal, midbuccal, distobuccal, mesiolingual/palatal, midlingual/palatal, distolingual/palatal). The distance from the gingival margin to the base of the periodontal pocket was recorded. Measurements were rounded to the nearest millimeter. Mean probing depth values were calculated per participant. Greater probing depth values indicate more severe periodontal tissue destruction and disease severity.

    At Day 0, Day 30, Day 90

  • Clinical attachment level

    Clinical attachment level was measured in millimeters using a calibrated periodontal probe at six sites per tooth. CAL was calculated as the distance from the cemento-enamel junction (CEJ) to the base of the periodontal pocket. In cases of gingival recession, the recession value was added to the probing depth; in cases of gingival enlargement, it was subtracted accordingly. Mean CAL values were calculated per participant. Higher CAL values indicate greater loss of periodontal attachment and increased disease severity.

    At Day 0, Day 30, Day 90

  • Bleeding on probing

    Bleeding on probing was assessed at six sites per tooth using a calibrated periodontal probe. After gentle probing of the sulcus or periodontal pocket, the presence or absence of bleeding within 15 seconds was recorded. BOP was expressed as the percentage of bleeding sites relative to the total number of sites examined per participant. Higher percentages indicate increased gingival inflammation and active periodontal disease.

    At Day 0, Day 30, Day 90

  • Tooth mobility measurement

    Tooth mobility was quantified using a Periotest M device (Medizintechnik Gulden, Modautal, Germany). Periotest values (PTVs) between +10 and +30 indicated Miller Class II, and between +30 and +50 Miller Class III mobility.

    At Day 0, Day 30, Day 90

  • Masticatory performance

    Masticatory efficiency was assessed using the silicone cube chewing test. Standardized cubes(8 × 8 × 8 mm) were prepared from Optosil® (Heraeus Kulzer, South Bend, IN, USA) using a plexiglass mold, sterilized in an autoclave, and weighed for standardization. Participants were instructed to chew eight cubes for 20 cycles while seated upright. The procedure was visually monitored by the examiner and recorded on video to verify the number of cycles. The chewed material was collected, rinsed, and dried at room temperature for three days before analysis. Chewed samples were analyzed using a multiple-sieve system with apertures of 4.0, 2.0, 1.0, 0.5, and 0.25 mm (in accordance with the ISO standard). The participant rinsed their mouth with water to remove residual particles, expelling them into the same receptacles. The particles were washed with water, allowed to dry, and removed from the paper filter. The median particle size was calculated from the cumulative weight distribution.

    At Day 0, Day 30, Day 90

Secondary Outcomes (1)

  • Assessment of oral health-related quality of life

    At Day 0, Day 30, Day 90

Study Arms (2)

Periodontal teratment

ACTIVE COMPARATOR

Periodontitis patients underwent both non-surgical and surgical periodontal treatments.

Procedure: non-surgical periodontal treatmentProcedure: surgical periodontal treatment

Periodontal evaluation

NO INTERVENTION

Both Healthy controls and periodontitis patients went through periodontal examination.

Interventions

non-surgical periodontal treatment

Periodontal teratment

Periodontitis patients underwent surgical periodontal treatments.

Periodontal teratment

Eligibility Criteria

Age31 Years - 51 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ≥ 20 natural teeth
  • at least four functional chewing units (one molar pair = two units; one premolar pair = one unit).
  • positive bleeding on probing in ≥ four chewing units
  • probing depth ≥ 5 mm in ≥ four molar or premolar teeth
  • age between 20 and 45 years.

You may not qualify if:

  • Individuals with systemic diseases
  • pregnancy
  • smoking habits
  • recent antibiotic or anti-inflammatory use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Medipol University

Ankara, Ankara, 06010, Turkey (Türkiye)

Location

Related Publications (11)

  • Alkan A, Keskiner I, Arici S, Sato S. The effect of periodontitis on biting abilities. J Periodontol. 2006 Aug;77(8):1442-5. doi: 10.1902/jop.2006.060025.

    PMID: 16881814BACKGROUND
  • von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007 Oct 16;147(8):573-7. doi: 10.7326/0003-4819-147-8-200710160-00010.

    PMID: 17938396BACKGROUND
  • Solderer A, Kaufmann M, Hofer D, Wiedemeier D, Attin T, Schmidlin PR. Efficacy of chlorhexidine rinses after periodontal or implant surgery: a systematic review. Clin Oral Investig. 2019 Jan;23(1):21-32. doi: 10.1007/s00784-018-2761-y. Epub 2018 Dec 7.

    PMID: 30535817BACKGROUND
  • Caffesse RG, Sweeney PL, Smith BA. Scaling and root planing with and without periodontal flap surgery. J Clin Periodontol. 1986 Mar;13(3):205-10. doi: 10.1111/j.1600-051x.1986.tb01461.x.

    PMID: 3517073BACKGROUND
  • Pihlstrom BL, Ortiz-Campos C, McHugh RB. A randomized four-years study of periodontal therapy. J Periodontol. 1981 May;52(5):227-42. doi: 10.1902/jop.1981.52.5.227.

    PMID: 7017103BACKGROUND
  • Heitz-Mayfield LJ, Trombelli L, Heitz F, Needleman I, Moles D. A systematic review of the effect of surgical debridement vs non-surgical debridement for the treatment of chronic periodontitis. J Clin Periodontol. 2002;29 Suppl 3:92-102; discussion 160-2. doi: 10.1034/j.1600-051x.29.s3.5.x.

    PMID: 12787211BACKGROUND
  • Balci N, Alkan N, Gurgan CA. Psychometric properties of a Turkish version of the oral health impact profile-14. Niger J Clin Pract. 2017 Jan;20(1):19-24. doi: 10.4103/1119-3077.164353.

    PMID: 27958241BACKGROUND
  • van der Bilt A, Fontijn-Tekamp FA. Comparison of single and multiple sieve methods for the determination of masticatory performance. Arch Oral Biol. 2004 Feb;49(2):155-60. doi: 10.1016/j.archoralbio.2003.08.004.

    PMID: 14693210BACKGROUND
  • Pereira LJ, Gazolla CM, Magalhaes IB, Ramos-Jorge ML, Marques LS, Gameiro GH, Fonseca DC, Castelo PM. Treatment of chronic periodontitis and its impact on mastication. J Periodontol. 2011 Feb;82(2):243-50. doi: 10.1902/jop.2010.100178. Epub 2010 Jul 27.

    PMID: 20653435BACKGROUND
  • Tonetti MS, Van Dyke TE; working group 1 of the joint EFP/AAP workshop*. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAPWorkshop on Periodontitis and Systemic Diseases. J Periodontol. 2013 Apr;84 Suppl 4S:S24-S29. doi: 10.1902/jop.2013.1340019.

    PMID: 29537596BACKGROUND
  • van den Braber W, van der Bilt A, van der Glas HW, Bosman F, Rosenberg A, Koole R. The influence of orthognathic surgery on masticatory performance in retrognathic patients. J Oral Rehabil. 2005 Apr;32(4):237-41. doi: 10.1111/j.1365-2842.2004.01436.x.

    PMID: 15790376BACKGROUND

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: This prospective, controlled, longitudinal interventional study included a periodontitis group and a healthy control group. Patients diagnosed with Stage III, Grade B periodontitis received comprehensive periodontal therapy consisting of non-surgical treatment (scaling and root planing) followed by surgical therapy when indicated. All procedures were performed according to standard clinical guidelines. The periodontitis group was evaluated at three time points: baseline, after non-surgical therapy, and after surgical therapy. The healthy control group underwent a single baseline assessment and received no intervention. This within-subject longitudinal design allows assessment of treatment-related changes over time in clinical parameters, masticatory performance, and oral health-related quality of life. No randomization or blinding was applied; however, objective measurement tools were used to minimize assessment bias.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

February 21, 2026

First Posted

March 4, 2026

Study Start

December 1, 2019

Primary Completion

July 1, 2021

Study Completion

July 5, 2021

Last Updated

March 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available because of the participants consent.

Locations